Anlotinib Plus Docetaxel Vs. Docetaxel Alone for Advanced Non-Small-cell Lung Cancer Patients Who Failed First-Line Treatment: A Multicenter, Randomized Phase II Trial

Xingxiang Pu,Zemin Xiao,Jia Li,Zhijun Wu, Zhongxia Ma,Jie Weng,Maoliang Xiao,Yanhua Chen,Yongqing Cao,Peiguo Cao,Qianzhi Wang,Yan Xu,Kang Li,Bolin Chen,Fang Xu,Liyu Liu,Yi Kong,Hui Zhang,Huaxin Duan,Lin Wu

LUNG CANCER（2024）

引用 0|浏览35
暂无评分
关键词
Anlotinib,Docetaxel,Non-Small-Cell Lung Cancer,Second-Line Therapy,Immunotherapy-Pretreated
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要